ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and ...

For information regarding abstract submission, including abstract categories, guidelines, and policies, please review the pages linked below.

Conquer Cancer, the ASCO Foundation and AstraZeneca are collaborating to offer a Quality Improvement grant funding opportunity to develop and deliver strategies to improve guideline concordant care ...

The American Cancer Society (ACS) projects that by 2035, over 22 million people in the United States will be cancer survivors. For many cancer survivors, the side effects from cancer treatment can ...

Investigators studied the health records of more than 12,000 people with 7 types of cancer to see how 2 common types of diabetes medicines affect the spread of the disease. This real-world data shows ...

Several factors increase the chance of developing breast cancer, including having a body mass index (BMI) classified as overweight (BMI between 25 and 30) or obese (BMI of 30 or higher). BMI is a ...

High-grade serous ovarian carcinoma (HGSOC) is the most common form of ovarian cancer and accounts for 70% to 80% of all ovarian cancer deaths. People with advanced ovarian cancer usually have surgery ...

In 2024, the American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) joined together to build a comprehensive online resource for people with cancer and their support ...

Easy-to-read summaries of exciting new research from ASCO's scientific meetings.

If you are not a United States citizen and plan to attend the ASCO Quality Care Symposium, advance planning is critical. Consider the following when making your plans to travel to the United States ...

ASCO® Guidelines Assistant is an interactive AI tool developed by ASCO and Google Cloud. The tool allows oncologists to quickly search and use ASCO Guidelines through a simple, intuitive chat. Quickly ...

Mortality trend from multiple myeloma with hypertensive diseases as a contributing cause in the United States, 1999–2024: A CDC WONDER analysis across age, sex, and geographic variables.